Asbury R F, Blessing J A, McGuire W P, Hanjani P, Mortel R
University of Rochester School of Medicine, NY.
Am J Clin Oncol. 1990 Feb;13(1):39-41. doi: 10.1097/00000421-199002000-00011.
Twenty-one evaluable patients with advanced carcinoma of the endometrium were treated with aminothiadiazole at a dosage of 125 mg/m2 weekly. Twelve had received prior chemotherapy. Seven patients had stable disease; 14 had increasing disease. There were two life-threatening toxic episodes. Aminothiadiazole used in this dosage and schedule has negligible activity in previously treated patients with carcinoma of the endometrium.
